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Huntington disease (HD) is associated with early psychiatric symptoms including anxiety and depression. Here, we demonstrate that
wild-type huntingtin, the protein mutated in HD, modulates anxiety/depression-related behaviors according to its phosphorylation at
serines 1181 and 1201. Genetic phospho-ablation at serines 1181 and 1201 in mouse reduces basal levels of anxiety/depression-like
behaviors. We observe that the reduction in anxiety/depression-like phenotypes is associated with increased adult hippocampal neuro-
genesis. By improving the attachment ofmolecularmotors tomicrotubules, huntingtin dephosphorylation increases axonal transport of
BDNF, a crucial factor for hippocampal adult neurogenesis. Consequently, the huntingtin-mediated increasedBDNFdynamics lead to an
increased delivery and signaling of hippocampal BDNF. These results support the notion that huntingtin participates in anxiety and
depression-like behavior and is thus relevant to the etiology of mood disorders and anxiety/depression in HD.
Introduction
Huntingtondisease (HD) is a neurodegenerative disorder involv-
ing severe cognitive deterioration and motor impairment. Anxi-
ety and depression are prevalent components of HD (Kirkwood
et al., 2001; Duff et al., 2007): they are present early in the disease,
before the diagnosis and preceding chorea by 10 years or more.
Their etiology in HD is not known.
The mutation that causes HD is an abnormal polyglutamine
(polyQ) expansion in the huntingtin (HTT) protein.HD is due to
both the loss of the normal function(s) of wild-type HTT and the
gain of toxic functions of polyQ-HTT (Zuccato et al., 2010).
Wild-type HTT is an essential protein required for embryonic
development (Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al.,
1995; White et al., 1997). It is important for the formation of the
nervous system and embryonic neurogenesis in mouse (White et
al., 1997; Reiner et al., 2001; Godin et al., 2010). However, noth-
ing is known about the role of HTT during adult neurogenesis.
The neurogenesis hypothesis of depression postulates that
a decrease in the production of newborn granule cells in the
dentate gyrus is related to the pathophysiology of major de-
pressive disorders, whereas enhanced hippocampal neurogen-
esis is required for beneficial antidepressant treatment
(Samuels and Hen, 2011; Petrik et al., 2012). In agreement,
mice administered corticosterone show decreased neurogen-
esis associated with behavioral abnormalities mimicking de-
pressive symptoms observed in humans (David et al., 2009).
Conversely, chronic treatment with antidepressants increases
neurogenesis in the dentate gyrus of the hippocampus in ro-
dents and human (Malberg et al., 2000; Santarelli et al., 2003;
Perera et al., 2011; Rainer et al., 2011; Boldrini et al., 2012).
Studies have described a causative role for adult neurogenesis
in the response to antidepressants in stress mouse models
(David et al., 2009).
The brain-derived neurotrophic factor BDNF is at the cross-
roads of depression and neurogenesis. Although its expression is
reduced by stress and in major depression disorder, it is induced
by antidepressant treatment (Autry and Monteggia, 2012). Part
of the effects of BDNF in the regulation of mood disorders has
been linked to hippocampal neurogenesis. BDNF regulates den-
dritic maturation and survival of newly generated neurons in the
dentate gyrus of the hippocampus (Krishnan and Nestler, 2008).
BDNF is also a key factor in HD. BDNF is required by striatal
neurons, the most affected neurons in HD, to survive and differ-
entiate. However, the striatal production of BDNF is not suffi-
cient (Baquet et al., 2004), and BDNF is provided to these
neurons by cortical neurons through axonal transport. This mi-
crotubule (MT)-based transport depends on HTT and is altered
in HD (Gauthier et al., 2004).
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We previously identified two cyclin-dependent kinase 5
(Cdk5) phosphorylation sites on HTT: serines 1181 and 1201
(S1181/1201) (Anne et al., 2007). Although phosphorylation
at these sites is important to regulate oxidative stress- and
polyQ-HTT-mediated toxicity in neuronal cultures, their func-
tion in physiological conditions is unknown (Anne et al., 2007).
We report here that absence of phosphorylation ofHTT at S1181/
1201 reduces anxiety/depression-like behaviors and increases
hippocampal neurogenesis in mouse.
Materials andMethods
Generation of mutant mouse lines. HdhS1181A/S1201A andHdhS1181D/S1201D
mutant mouse lines were established at the MCI/ICS (Mouse Clinical
Institute, Illkirch, France; http://www-mci.u-strasbg.fr). The targeting
vectors were constructed as follows. A 0.7 kb fragment encompassing the
twomutations in exon 27was amplified by PCR using 129S2/SvPas DNA
as a template and subcloned in an MCI proprietary vector resulting in
step 1 vectors. These MCI vectors had a floxed neomycin resistance cas-
sette. The two 3 and 5 homology arms were subsequently subcloned in
step1 plasmid to generate the final targeting construct. The linearized
constructs were electroporated in 129S2/SvPas mouse embryonic stem
(ES) cells. After selection, targeted clones were identified by PCR using
external primers and further confirmed by Southern blot with 5 and 3
external probes. Positive ES clones were injected into C57BL/6J blasto-
cysts, and male chimeras derived gave germline transmission.
All experiments were performed with homozygous HdhS1181A/S1201A
andHdhS1181D/S1201Dmice derived from heterozygous crosses. The wild-
type animals are originating from the two types of littermates (50/50).
Littermates were kept in a 12 h light/dark cycle in plastic cages, and
allowed to eat and drink ad libitum. Bromodeoxyuridine [(BrdU) 150
mg/kg] was injected twice daily (morning and afternoon) during 3 d by
intraperitoneal injections. Mice were sacrificed 3.5 weeks following the
last injection.
All experiments were performed in strict accordance with the recom-
mendations of the European Community (86/609/EEC) and the French
National Committee (87/848) for care and use of laboratory animals
(permissions 91-448 to S.H. and 92-256B to D.J.D).
Genotyping.DNAwas prepared from tails biopsies frommutant mice.
Mutated regions containing LoxP sequence were genotyped using 5-GC
ACCCAGAGAACTCCTCCC-3 and 5-CCTTCTCTTAGAGGGGACAT
GGC-3 primers for HdhS1181A/S1201A mice, and 5-CTTGTTCTCCAGGT
TCTTTCTCCTTCC-3 and 5-CATATTGGAGAGCATGGGTCACATCT
GG-3 primers for HdhS1181D/S1201D mice in Thermopol buffer (Biolabs),
200 M dNTPs, 1 M primers, and 5U/l TaqDNA polymerase (Biolabs).
Cycling conditions were 3min at 94°C, 2 (1min at 94°C; 1min at 62°C; 1
min at 72°C), 30 (30 s at 94°C; 30 s at 62°C; 30 s at 72°C), 3 min at 72°C.
PCR products were separated on a 2% agarose gel to distinguish wild-type
frommutant band.
Sequencing. Sequencing was carried on by MWG operon (France)
from PCR products purified using Nucleospin Extract II (Macherey-
Nagel). The sequences obtained were aligned to huntingtin gene se-
quence from PubMed with the Serial cloner 2.0 software (available at:
http://serialbasics.free.fr/Serial_Cloner.html).
Behavioral testing. Behavioral testing was performed as described pre-
viously (David et al., 2009).
Immunohistochemistry.Mice were anesthetized with ketamine (250 mg/
ml; 100l/10gofbodyweight)by intraperitoneal injections.Micewere then
perfused with a saline solution and, after complete blood clearing, by para-
formaldehyde (PFA) 4%. Brains were removed and kept in PFA 4% over-
night. They were then cryoprotected in 30% sucrose. Frozen blocks were
sectioned at 35mand sliceswere kept free-floating inPBSwith 0.1%azide.
Serial sections were made, each one covering the whole hippocampus.
TUNEL staining was performed with DeadEnd Fluorometric TUNEL
System (Promega) according to the manufacturer’s instruction, with the
addition of a prior permeabilization step in 0.5% Triton X-100 in PBS
during 1 h at room temperature.
For BrdU immunostaining, slices were first treated using 0.01 M citric
acid. Peroxydase was quenched by 0.3% H2O2 in 0.1 M TBS. Slices were
then permeabilized with 0.1% trypsin in 0.1 M Tris HCl with 0.1% CaCl,
and transferred in 2 N HCl solution. Slices were blocked with 10% nor-
mal donkey serum in PBS 0.5% Tween 20. They were incubated with rat
anti-BrdU Antibody (AbD Serotec) in blocking solution overnight. Sec-
ondary biotinylated donkey anti-rat was used and revelation was per-
formed using Vector ABC Elit kit and Vectastain DAB kit. Sections were
counterstained with hematoxylin, dehydrated in ethanol, delipidated in
xylene, and mounted with Entellan.
For doublecortin (DCX) immunostaining, slices were washed with 0.1 M
TBS. Peroxydase were quenched by 0.3% H2O2 in 0.1 M TBS. Slices
were blocked with 10% normal donkey serum in 0.1 M TBS with 0.5%
Triton X100. Slices were then incubated overnight at 4°C in blocking
solution containing goat anti-DCX antibody (Santa Cruz Biotechnol-
ogy). After washing, slices were incubated with biotinylated donkey anti-
goat. Revelation was performed as described for BrdU immunostaining
and sections were dehydrated and mounted as before.
For Sholl analysis, DCX-positive cells with tertiary, relatively untrun-
cated dendritic branches were traced for each 35 m hippocampal slice
using Neurolucida software (MicroBrightField) on an Olympus BX51
microscope equipped with a motorized stage device and 100 immer-
sion oil objective. DCX immunohistochemistry was done to maximize
the labeling of dendrites. Sholl analysis for dendritic complexity was
performed using the accompanying software (NeuroExplorer; Micro-
BrightField, version 10), calculating dendritic complexity including den-
dritic length and number of intersections (branch points). All samples
were number coded, and analysis was done blind to treatment.
RNA extraction, microarray, and real-time PCR. Total RNA was isolated
from frozen hippocampi usingmiRNeasymini kit (Qiagen). Total RNAs
were monitored using the Nanodrop (Thermo) and the Agilent Bioana-
lyzer. Total RNA RIN values were between 8.3 and 9.1. RNA samples
were retrotranscribed using the First-Strand cDNA Synthesis Kit (Invit-
rogen). cDNAs were diluted 1:10 and submitted to RT-PCR with
7900HT Fast real time PCR system (Applied Biosystems) using power
SYBR Green PCR Master mix (Applied Biosystems). Oligonucleotide
pairs were for BDNF IV (5-AGCTGCCTTGATGTTTACTTT-3 and
5-TCCGTGGACGTTTACTTCTT-3), BDNF IIA (5-TACTTCATCC
AGTTCCACCAG-3 and 5-CAAGTTGCCTTGTCCGT-3), BDNF IIB
(5-AAGCTCCGGTTCCACCAG-3 and 5-TGCTTCTTTCATGGG
CG-3), BDNF IIC (5-GTGGTGTAAGCCGCAAAGA-3 and 5-CGTG
GACGTTTGCTTCTTTC-3),-actin (5-GATCTGGCACCACACCTT
CT-3 and 5-GGGGTGTTGAAGGTCTCAAA-3), GAPDH (5-GTGG
ACCTCATGGCCTACAT-3 and 5-TGTGAGGGAGATGCTCAGTG-
3), and cyclophilinG (5-AACTCCCAGCCTGCTTCATA-3 and 5-CT
GGATCTGGAAGGAGTTCG-3). Primers for BDNF IIA, IIB, and IIC
were previously described (Kobayashi et al., 2008; Gambazzi et al., 2010).
Geometric averaging of -actin, GAPDH, and cyclophilin G was used as
internal control.
Immunoblotting and immunoprecipitation.Micewere killed by cervical
translocation. Brains were removed and hippocampi were collected and
frozen in liquid nitrogen. Hippocampi were lysed in 50 mM Tris HCl, 2
mM EGTA, 10 mM -mercaptoethanol 0.1% (v/v), 10 g/ml aprotinine,
10 g/ml leupeptine, 1 mM sodium orthovavadate. Primary antibodies
used in this study are as follows: anti-huntingtin (HU-4C8-As, Euromedex;
D7F7, Cell Signaling Technology; P-HTT-S1201 and P-HTT-S1181) (Anne
et al., 2007), anti--tubulin (clone DM1A, Sigma-Aldrich), anti-BDNF
(SantaCruzBiotechnology), anti-CREBandanti-pCREB(phospho-Ser133,
Cell Signaling Technology), anti-ERK and anti-pERK (p42/p44, phospho-
Thr202/Tyr204; Cell Signaling Technology). HRP-conjugated goat anti-
mouse and anti-rabbit secondary antibodies were purchased from Jackson
Immunoresearch Laboratories.
For immunoprecipitation, protein G-sepharose beads (Sigma-
Aldrich) were incubated overnight with anti-HTT antibodies (4C8 or
D7F7). Beads conjugated to 4C8 were incubated for 5 h with brain ly-
sates, washed, and analyzed by immunoblotting.
Videomicroscopy experiments and analyses. Rat primary hippocampal
neurons andP0 cortical primary neurons frommice of various genotypes
were prepared as previously described (Anne et al., 2007) and electropo-
rated with rat or mouse neuron Nucleofector (Amaxa), respectively.
Neurons were electroporated as indicated with BDNF-mCherry (Zala et
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al., 2008); HTT-1301; HTT-1301-S1181A/S1201A; HTT-1301-S1181D/
S1201D constructs (Anne et al., 2007), and a siRNA (UUACUGUCUA-
CUGGAUUCATT annealed with UGAAUCCAGUAGACAGUAATT)
that targets a sequence outside the region coding theN-terminal 1301 aa
of HTT.
One million neurons were plated in the upper chambers of dual mi-
crochambers coated with a mixture of poly-D-lysine (0.5 mg/ml) 
laminin (10 g/ml) and cultivated 5 d in neurobasal supplemented with
2% B27, 1% glutamax, and 1% penicillin/streptomycin.
Microchambers and neuronal plating were previously described (Zala
et al., 2013). Briefly, siliconwafer obtained by photolithographywas used
to create the master with SU8 resin. The channels are 3 m high, 5 m
wide, and 450 m long. Silicon elastomer with its curing agent was used
(PDMS, Sylgard 184, Dow Corning) to create the devices. The microflu-
idic devices were then coatedwith poly-D-lysine (0.5mg/ml) and laminin
(10 mg/ml) overnight at 4°C and then washed three times with neuronal
medium. One million neurons were plated in the cell body/proximal
compartment of the chamber.
The microscope and the chamber were kept at 37°C. Images were
recorded with a 100 PlanApo N.A. 1.4 oil-immersion objective on a
Leica DM IRBE microscope and collected every 200 ms in stream mode
with 150 ms of exposure and a 2 2 binning using a Micromax camera
(Ropper Scientific) controlled by MetaMorph software (Molecular De-
vices). Videos, kymographs, and analyses were generated with ImageJ
software (http://rsb.info.nih.gov/ij/). Maximal projection was per-
formed to identify the vesicles paths, which in our system corresponds to
vesicle movements in axons. Kymographs and analyses were generated
with the KymoToolBox, a home-made plug-in previously described
(Zala et al., 2013).
Measure of transport-dependent BDNF release. Rat primary hippocam-
pal neurons and P0 cortical primary neurons frommice of various geno-
types were electroporated with a construct expressing a nontagged
version of human BDNF (Zala et al., 2008). To measure transport-
dependent release, cells were depolarized (treatment for 20 min with
neuronal culture medium with 28 mM KCl, 30 mM CaCl2 and 30 mM
NaCl) and the supernatant recovered (K1 fraction). After washings, neu-
rons were incubated 30 min with normal neuronal culture medium,
depolarized again and the new supernatant was recovered (K2 frac-
tion). Finally, cells were lysed (L fraction) and the concentration of
BDNF in all fractions was analyzed using BDNF Emax Immunoassay
system (Promega).
BDNF immunoenzyme assays on hippocampi extracts. Hippocampi
were lysed in 100 mM PIPES (pH 7), 500 mM NaCl, 0.2% Triton X100,
0.1%NaN3, 2% BSA, 2 mM EDTA, 10 m leupeptine, 0.3 m aprotinin,
1 m pepstatin, 200 m PMSF. The amount of BDNF was measured in
supernatants and cell lysates using the BDNFEmax Immunoassay system
(Promega) and expressed relative to the content of proteins in cells.
BDNF levels in hippocampal extracts are reported in ng/mg wet tissue
weight.
Microtubule preparation. MTs were prepared from HeLa cells trans-
fected with HTT-1301; HTT-1301-S1181A/S1201A and HTT-1301-
S1181D/S1201D. Cells were scrapped with PBS after 1 h treatment at
37°C with 1m taxol. After a 5min centrifugation at 1000 g, the pellet
was dissociated in PM2G buffer (0.1 M PIPES, pH 6.8, 2 M glycerol, 5 mM
MgCl2 , 2 mM EGTA) and diluted with the same volume of PM2G con-
taining 0.4%NP40. Another 5min centrifugation at 1000 g followed a
15 min incubation at 37°C. The supernatant underwent a last centrifu-
gation at 10,000 g (45 min). The MTs containing pellet obtained was
quickly washed with PM2G and dissolved in SDS buffer (31mM Tris, pH
6.8, 1% SDS, 5% glycerol). The supernatant was diluted by addition of an
equal volume of 2 SDS buffer.
Immunofluorescence. Cells were transfected with BDNF-mCherry and
HTT-1301; HTT-1301-S1181A/S1201A, and HTT-1301-S1181D/
S1201D. Cells were fixed 2min in coldmethanol with 2% paraformalde-
hyde. Immunofluorescence was performed for tubulin (mouse anti--
tubulin; clone DM1A, Sigma-Aldrich) and for the cherry-tag (rabbit
anti-cherry; Recombinant Protein and Antibody Platform of the Institut
Curie). Secondary antibodies, purchased from Jackson Immunoresearch
Laboratories, were goat anti-mouse-A488 and anti-rabbit-A555. Cover-
slips were mounted in 0.1 g/ml Mowiol 4-88 (Calbiochem) in 20% glyc-
erol. Acquisitions of images were performed with a confocal Leica SP5
microscope. Analysis of BDNF vesicles on MTs was performed using
ImageJ software (http://rsb.info.nih.gov/ij/).
Statistical analyses. Statview 4.5 software (SAS Institute) was used for
statistical analysis. The criterion for statistical significance was set at p
0.05. Data are expressed as meanSEM.
Results
Generation ofHdhS1181A/S1201A andHdhS1181D/S1201Dmice
We used homologous recombination to generate knock-in mice
in which the codons for serines at positions 1181 and 1201 of the
gene encoding mouse HTT (Hdh) were replaced by codons for
alanine (HdhS1181A/S1201A) or aspartic acid (HdhS1181D/S1201D)
(Fig. 1A). Using expression of exogenous Cdk5, and inhibition of
endogenous Cdk5 by RNA interference or pharmacological ap-
proaches in primary cultured neurons, we have previously shown
that these substitutions mimic the absence of phosphorylation
and constitutive phosphorylation of HTT by Cdk5 on these sites
(Anne et al., 2007). Genomic DNA from homozygous knock-in
mice from each genotype was sequenced to confirm the replace-
ment of the AGT codons by the GCT codons (HdhS1181A/S1201A)
and by the GAT codons (HdhS1181D/S1201D) (Fig. 1B). Wild-type,
HdhS1181A/S1201A and HdhS1181D/S1201D mice can be discriminated
by genotyping with specific primers recognizing sequences
around the residual intronic LoxP sequence (Fig. 1C).
We evaluated the phosphorylation ofHTT at serines 1181 and
1201. Lysates were prepared from adult cortices from the mice of
the three genotypes, and HTT was immunoprecipitated and an-
alyzed by immunoblotting with two phosphorylation state-
specific polyclonal antibodies. Anti-P-HTT-S1181 specifically
recognizes phosphorylated serine 1181 and anti-P-HTT-S1201
specifically recognizes phosphorylated serine 1201 (Anne et al.,
2007). Both antibodies recognized HTT in wild-type mouse ex-
tracts showing that HTT is phosphorylated at these sites in the
cortex of adult mouse (Fig. 1D). Neither anti-P-HTT-S1181 nor
anti-P-HTT-S1201 detected HTT immunoprecipitated from
HdhS1181A/S1201A and HdhS1181D/S1201D cortical extracts. This is in
agreement with our previous findings that anN-terminal 1301
amino-acid fragment of wild-type HTT with S1181D/S1201D
mutations is not recognized by the specific phospho-
antibodies (Anne et al., 2007). Similar results were obtained
using striatal and hippocampal extracts (data not shown).
These results demonstrate that serines 1181 and 1201 are
phosphorylated in the brain of adult wild-type mice, and are
modified in HdhS1181A/S1201A and HdhS1181D/S1201D mice.
HdhS1181A/S1201A mice show reduced anxiety and depression-
related behavior
HdhS1181A/S1201A andHdhS1181D/S1201Dmice are viable, fertile, and
do not show amotor phenotype (data not shown). To investigate
their anxiety/depressive-like state, we applied standardized be-
havioral tests routinely used to evaluate the efficacy of anti-
depressive drugs on mice suffering from depression-related
behavior (David et al., 2009).We tested the behavior ofwild-type,
HdhS1181A/S1201A, and HdhS1181D/S1201D 12-week-old mice in the
open field paradigm (OF).HdhS1181A/S1201Amice spentmore time
than wild-type mice in the center, indicating less anxiety (Fig.
2A).HdhS1181D/S1201D behaved in the same way as wild-typemice.
The ratio of total distance moved in the center to total distance
moved was higher for HdhS1181A/S1201A mice than wild-type and
HdhS1181D/S1201D mice (Fig. 2A). This demonstrates that the ab-
sence of phosphorylation of HTT at serines 1181/1201 reduces
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the anxiety-like phenotype in mice without affecting locomotor
activity. Similarly, in the novelty suppressed feeding test (NSF),
the latency to feeding was shorter for HdhS1181A/S1201A mice than
wild-type andHdhS1181D/S1201D mice (Fig. 2B), with no cofound-
ing feeding effect (right graph).
We also evaluated the grooming behavior, that is an index of a
depressed-like state (Surget et al., 2008). After a 10% sucrose
solution was sprayed on the mouse snout,HdhS1181A/S1201A spent
more time grooming than wild-type and HdhS1181D/S1201D mice
(Fig. 2C).
There was no difference between female and male behavior,
for each genotype, in any of the behavioral tests. Collectively,
these various findings show that abolition of HTT phosphoryla-
tion at S1181/S1201 reduces both anxiety and depression-related
behavior in mice.
Ablation of HTT phosphorylation at S1181/S1201 promotes
survival andmaturation of newborn neurons in the
hippocampal dentate gyrus
The hippocampus is important for the regulation of mood disor-
ders and hippocampal neurogenesis is involved, at least in part, in
the regulation of the response to antidepressants (for review, see
Samuels and Hen, 2011). We thus focused our attention on neu-
rogenesis in the dentate gyrus of the hippocampus in 14-week-
old animals that had performed the behavioral tests. We first
estimated the number of proliferating cells using Ki67 and apo-
ptotic cell death using a TUNEL assay. We did not observe any
differences in the numbers of proliferating and apoptotic cells in
the dentate gyrus between the different genotypes (data not
shown) (Fig. 3A). We next assessed the survival rate of newly
generated neurons by labeling with the thymidine analog BrdU
(Fig. 3B). The number of newborn cells surviving 3 weeks after
BrdU administration in the dentate gyrus was higher in the hip-
pocampi ofHdhS1181A/S1201A than wild-type andHdhS1181D/S1201D
animals.
We then quantified the number of doublecortin (DCX)-
positive neurons: DCX is produced by neuronal progenitors and
immature neurons and is a marker for adult neurogenesis. We
found no differences between the quantities of new immature
DCX-positive neurons produced in the three genotypes (Fig. 3C).
We then analyzed the DCX-positive neurons according to the
degree of complexity of their dendrites (Orvoen et al., 2011) (Fig.
3D). There were more DCX-positive neurons with quinary den-
drites and a higher maturation index in HdhS1181A/S1201A than
wild-type andHdhS1181D/S1201D animals. Thus, to further examine
this latest effect, we performed a Sholl analysis to study dendritic
arborization of DCX-positive neurons (Fig. 3E). Sholl analysis
quantifies dendritic complexity and growth according to the dis-
Figure 1. Generation of HdhS1181A/S1201A and HdhS1181D/S1201D Mice. A, Schematic representation of the Hdh locus. B, Mouse HTT sequence for wild-type, HdhS1181A/S1201A and HdhS1181D/S1201D
around the serines of interest. Data correspond to the noncoding strand. C, Representative PCR genotyping. Top, photo of a gel obtained after themigration of PCR products. hetero, heterozygous;
homo, homozygous. Bottom, primers location and size of PCR products obtained for wild-type, HdhS1181A/S1201A on the left and HdhS1181D/S1201D on the right. D, HTT (4C8) immunoprecipitates (IP)
of extracts from wild-type, HdhS1181A/S1201A and HdhS1181D/S1201D cortices are immunoblotted using anti-HTT (4C8), anti-P-HTT-S1181, and anti-P-HTT-S1201 antibodies.
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tance from the soma by considering con-
centric circles around the soma (Wang et
al., 2008; Sahay et al., 2011). The numbers
of intersections at 60–140 m from the
soma (left graph) and dendritic length
(right graph) were both higher in
HdhS1181A/S1201A than wild-type and
HdhS1181D/S1201D mice.
These data show that the presence of a
nonphosphorylatable HTT at positions
S1181/S1201 is associated with greater
neurogenesis due to increased survival
and dendritic maturation of the newborn
neurons in the dentate gyrus of the adult
hippocampus.
BDNF levels and induced-signaling are
increased in the hippocampus of
HdhS1181A/S1201Amice
Given that the absence of phosphoryla-
tion of HTT at S1181/1201 leads to in-
creased maturation and survival of
hippocampal neurons, we evaluated
BDNF levels and signaling in the hip-
pocampus of mice of the three genotypes.
Indeed, BDNF is a key factor specifically
regulating dendritic maturation and sur-
vival of newly generated neurons in the
dentate gyrus of the hippocampus (Krish-
nan and Nestler, 2008). We thus assayed
BDNF protein by ELISA in hippocampal
extracts (Fig. 4A). Total BDNF protein
abundance, including both pro-BDNF
and mature BDNF, was significantly
greater in HdhS1181A/S1201A than wild-type
and HdhS1181D/S1201D mice. We used im-
munoblotting to discriminate between
pro-BDNF and mature BDNF in hippocampal extracts of wild-
type, HdhS1181A/S1201A and HdhS1181D/S1201D mice (Fig. 4B). The
mature-BDNF/pro-BDNF ratio was very much higher in
HdhS1181A/S1201A hippocampal protein extracts.
To determine whether BDNF production was efficiently con-
verted into signaling, we studied the mitogen-activated protein ki-
nase (MAPK) pathway. This pathway is elicited by BDNF and plays
a role in adult neurogenesis (Cohen and Greenberg, 2008). Binding
of BDNF to its receptor, the tropomyosin-related kinase receptor
type B (TrkB), results in the sequential activation of Erk and the
cAMP responsive element binding protein (CREB). We therefore
used immunoblotting to evaluate the levels of total andactivatedErk
andCREB in hippocampal extracts from the threemouse lines (Fig.
4C). The ratio of active to total amounts of these targets was signifi-
cantly higher in HdhS1181A/S1201A than wild-type and HdhS1181D/S1201D
mouse lines. Therefore, BDNF production and activation of Erk and
CREBare elevated in the hippocampus ofHdhS1181A/S1201Amice.
Neuronal activity-induced bdnf transcript IV is elevated in
the hippocampus ofHdhS1181A/S1201Amice
We investigated themechanisms bywhichHTT phosphorylation
status at S1181/S1201 affects on BDNF. BDNF expression is con-
trolled bymultiple promoters that are used in activity-dependent
and tissue-specific manners (for review, see Cohen and Green-
berg, 2008; Zheng et al., 2012). Interestingly, wild-type hunting-
tin acts in the cytoplasm of neurons to regulate the availability of
repressor element-1 transcription factor/neuron restrictive si-
lencer factor (REST/NRSF) to its nuclear neuron restrictive si-
lencer element (NRSE) binding site on BDNF promoter II
(Zuccato et al., 2003). We thus evaluated the amounts of bdnf
exon IIA, IIB, and IIC transcripts in the hippocampus of
HdhS1181A/S1201A, HdhS1181D/S1201D, and wild-type mice by quan-
titative PCR (Fig. 4D). The expression of these transcripts was
similar among the three genotypes.
We next assessed the expression of a neuronal activity-
induced bdnf transcript (promoter IV). Indeed, BDNF exon IV
transcription is up-regulated by BDNF itself and by CREB
through a calcium regulatory element present in this region (Cohen
andGreenberg, 2008; Zheng et al., 2012).HdhS1181A/S1201A exhibited
a higher expression of neuronal activity-induced bdnf than the
HdhS1181D/S1201D and wild-type animals (Fig. 4D). Thus, although
BDNF transcripts levels are increased in HdhS1181A/S1201A animals,
thephosphorylation statusofwild-typeHTTdoesnot affect its func-
tion as a transcription regulator for the bdnf promoter. Rather, our
data suggest that inHdhS1181A/S1201Amice the increased BDNF pro-
duction and signaling leads to a subsequent increased activity-
dependent BDNF transcription.
Unphosphorylated HTT increases BDNF transport
and release
Another key event in the regulation of BDNF signaling is its MT-
based vesicular transport, a process facilitated by HTT (Gauthier
Figure2. HdhS1181A/S1201Amice show reduced anxiety/depression-like behavior comparedwithHdhS1181D/S1201Dandwild-type
mice. A, Open Field test. Anxiety is measured as the mean of the total time spent in the center (ANOVA F(2,146) 12.505;
***p 0.0001) and the distance in the center over total ambulatory distance (ANOVA F(2,146) 10.609; ***p 0.0001).
Representative trajectories followed by a mouse of each genotype during one session are shown in the three squares.
B, Novelty suppressed feeding paradigm. The anxious/depressed-like phenotype of each group of mice is measured as the
latency to feed (ANOVA F(2,144) 7.448; ***p 0.001). The food consumption during a 5 min session is shown for each
group of mice (ANOVA F(2,144) 0.104; p 0.901). C, Splash test. The depression-related phenotype is measured by the
grooming duration after 10% sucrose solution is sprayed on the mouse coat (ANOVA F(2,144)  4.491; *p  0.05).
All graphs: n 40 mice per group; Values plotted are meanSEM. Significant ANOVAs were followed up with Fisher’s
PLSD test: NS, not significant; *p 0.05, **p 0.01, and ***p 0.001.
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Figure 3. The behavioral effects observed in mice expressing unphosphorylated HTT are mediated by a neurogenesis-dependent mechanism. A, Quantification of the total number of TUNEL-
positive cells in the dentate gyrus per mouse (n 3) from each genotype (ANOVA F(2,6) 0.833; p 0.4793). B, Protocol used to measure neuronal survival and representative immunostaining
for BrdU-positive cells in the dentate gyrus of wild-type, HdhS1181A/S1201A and HdhS1181D/S1201D mice. Nuclei are counterstained with hematoxylin. Scale bar, 50 m. The graph represents the
quantitative assessment of themean total number of BrdU-positive cells in the dentate gyrus permouse (n 6) from each genotype (ANOVA F(2,17) 7.700; **p 0.01). C, Quantification of the
mean total number of DCX-positive neurons in the dentate gyrus per mouse (n 4) from each genotype (ANOVA F(2,9) 0.297; p 0.7498).D, Illustration of a DCX-positive (Figure legend continues.)
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et al., 2004; Caviston et al., 2007). We therefore tested the conse-
quences of phosphorylating HTT at S1181/S1201 on BDNF traf-
ficking by expressing constructs encoding theN-terminal 1301 aa
of wild-type HTT with either intact S1181/S1201, or S1181A/
1201A, or S1181D/S1201D mutations (HTT-1301; HTT-1301-
S1181A/S1201A; HTT-1301-S1181D/S1201D) (Fig. 5A). These
constructs contain the domains required for the interaction be-
tweenHTT andmolecularmotors, and increase axonal transport
when expressed in neurons (Caviston et al., 2007; Pardo et al.,
2010). To ensure that the observed effects were due solely to the
ectopic expression of the various constructs and their different
S1181 and S1201 status, we used primary cultures of rat hip-
pocampal neurons in which endogenous HTTwas silenced using
small interfering RNA (siRNA). The expression of these con-
structs was not affected by the siRNA used because it targets a
different portion of the HTT gene. Neurons were also coelectro-
porated with BDNF-mCherry and plated in microchambers de-
rived from a previously described microfluidic culture platform
(Taylor et al., 2005). Our device contains channels that are 5 m
wide, 450 m long, and 3 m high, and allows CNS axons to
grow into a fluidically isolated environment free of any chemo
attractants or trophic factors. Embryonic rat cortical neurons can
extend long processes into the channels, but only axons can reach
the distal chamber located 450 m away from the proximal
chamber containing the cell bodies and most of the dendrites.
After 4 d of culture in vitro, we quantified axonal transport in the
distal part of the microchamber as anterograde and retrograde
according to their direction relative to the cell bodies.
Both anterograde and retrograde velocities of BDNF vesicles
were higher for HTT unphosphorylated at S1181/S1201 than for
HTT with intact serines or S1181D/S1201D substitutions (Fig.
5A).We next used a BDNF release assay that is strictly dependent
upon BDNF transport to test the ability of neurons to release
BDNF (Gauthier et al., 2004). BDNF release was measured by
ELISA after two successive KCl-induced depolarizations (K1 and
K2). The first depolarization allowed the release of the readily
releasable pool at the membrane, and the second that of the pool
reconstituted throughMT-based transport. K2 is thus a measure
of transport-dependent release. Neurons were coelectroporated
with siRNA targeting endogenous HTT, BDNF, and the con-
structs encoding HTT-1301, HTT-1301-S1181A/S1201A, or
HTT-1301-S1181D/S1201D.The transport-dependent release by
neurons expressing unphosphorylatable HTT was higher than
that by neurons expressing HTT or HTT-S1181D/S1201D (Fig.
5B). Thus, BDNF transport and subsequent release are increased
when HTT is unphosphorylatable at S1181/S1201.
We then evaluated BDNF transport and release inmore phys-
iological conditions. Primary cultures of newborn cortical neu-
rons from wild-type, HdhS1181A/S1201A and HdhS1181D/S1201D mice
were electroporated with BDNF-mCherry and the dynamics of
BDNF-mCherry-containing vesicles studied as described for Fig-
ure 5A (Fig. 5C). When endogenous HTT was not phosphory-
lated, transport of BDNF increased: anterograde and retrograde
velocities of BDNF vesicles were higher in HdhS1181A/S1201A neu-
rons than controls, and the percentage of vesicles pausing was
lower. Kymographs generated from the video recordings illus-
trated these findings (Fig. 5D). We also investigated the subse-
quent release of BDNF upon mutation of endogenous HTT and
observed greater transport-dependent BDNF release by
HdhS1181A/S1201A neurons than wild-type and HdhS1181D/S1201D
neurons (Fig. 5E).
These experiments demonstrate that BDNF transport and
subsequent release are significantly modified by the S1181/S1201
phosphorylation status of HTT.
Unphosphorylated HTT increases the attachment of motor
proteins and BDNF vesicles to microtubules
HTT promotes BDNF MT-dependent transport by scaffolding
motor proteins onMTs (Gauthier et al., 2004; Colin et al., 2008).
We assessed whether the phosphorylation status of HTT affects
the interactions between dynein/dynactin and MTs. We frac-
tionated the subcellular components of HeLa cells expressing
HTT-1301, HTT-1301-S1181A/S1201A, or HTT-1301-S1181D/
S1201D, and obtained MT and cytosolic fractions (Fig. 6A). Im-
munoblotting analyses (left) and corresponding quantifications
(right) revealed that the levels of HTT, the p150Glued subunit of
dynactin, and dynein were higher in the MT fraction of cells
expressing HTT-1301-S1181A/S1201A than in MT fractions of
cells expressing HTT-1301 or HTT-1301-S1181D/S1201D. HTT
associates with huntingtin-associated protein-1 (HAP1), and
HAP1 associates with p150Glued and the light chain of kinesin-1 to
stimulate MT-based transport (Engelender et al., 1997; Gauthier
et al., 2004; McGuire et al., 2006). However, the levels of HAP1
did not vary in the different MT fractions (data not shown).
We also coexpressed constructs encoding BDNF with HTT-
1301 or HTT-1301-S1181A/S1201A or HTT-1301-S1181D/
S1201D (Fig. 6B).We immunostained the cells for-tubulin and
BDNF, and quantified the number of BDNF vesicles onMTs. The
percentage of vesicles attached toMTs was significantly higher in
cells expressingHTT-1301-S1181A/S1201A than in cells express-
ing HTT-1301 or HTT-1301-S1181D/S1201D (Fig. 6B).
Together, these results provide strong evidence that the pres-
ence of S1181/S1201 unphosphorylatable HTT leads to the re-
cruitment of dynein/dynactin and BDNF vesicles to the MTs.
Discussion
The physiological functions of HTT in adulthood have been
largely overlooked. The only study specifically addressing this
aspect involved conditional loss of HTT from the postnatal
mouse forebrain and testis, and led to a degenerative neuronal
phenotype and sterility (Dragatsis et al., 2000). Here, by studying
the regulatory roles of HTT phosphorylation at S1181/1201, we
show that HTT affects neurogenesis in the dentate gyrus of the
hippocampus and also anxiety and depression-like behavior in
adult mouse. Our study further supports the idea that HTT has
essential biological functions in the adult brain, which are per-
turbed during HD progression leading to specific pathological
manifestations in patients.
Functions in neuronal transcription, intracellular dynamics, cil-
iogenesis and division have been attributed toHTT (Gauthier et al.,
2004; Cattaneo et al., 2005; Caviston et al., 2007; Godin et al., 2010;
Keryer et al., 2011). Therefore, HTT is implicated in central cellular
pathways important in development, in adults, and in disease pro-
4
(Figure legend continued.) neuron with quinary dendrites. White arrowheads point to den-
dritic nodes. Scale bar, 10m.Histograms show thequantification of themean total number of
neurons with quinary dendrite per mouse (n 3) from each genotype (ANOVA F(2,8) 8.848;
**p 0.01), and the maturation index (ANOVA F(2,8) 6.211; *p 0.05). The maturation
index is a normalization of the number of neuronswith quinary dendrites over the total number
of DCX-positive neurons. E, Sholl analysis of DCX-positive neurons. The graphs indicate the
number of intersections (left graph) and the dendritic length (right graph) according to the
distance from the soma for each condition (n 3 per group). All graphs: Values plotted are
meanSEM. Significant ANOVAswere followed upwith Fisher’s PLSD test; *p 0.05, **p
0.01, and ***p 0.001.
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cesses. The molecular biology of HTT is complex, but consistent
withHTT being a scaffold protein that coordinates diverse events at
thecellular level. For instance,HTTbinds to thedynein intermediate
chain and to the p150Glued subunit of dynactin via HAP1 to regulate
the intracellular trafficking of various organelles (Engelender et al.,
1997; Li et al., 1998; Gauthier et al., 2004; Caviston et al., 2007).
Phosphorylationof S421ofHTTregulates the assemblyof this com-
plex, specifically favoring anterograde transport (Colin et al.,
Figure4. BDNFexpression and signaling is increased inHdhS1181A/S1201Ahippocampi.A, BDNF total protein levels in thehippocampusofwild-type,HdhS1181A/S1201AandHdhS1181D/S1201Dmice are
measured by BDNF immunoenzyme assays (n 13 hippocampi per group; ANOVA F(2,39) 3.242; *p 0.05). B, Hippocampal extracts from mice of the different genotypes were analyzed by
immunoblotting for the presence of BDNF. The graph represents the quantitative assessment of the ratio of mature-BDNF/pro-BDNF (n 3 hippocampi per group; ANOVA F(2,6) 12.500; **p
0.01). C, Hippocampal extracts frommice (n 3 hippocampi per group) of the different genotypes are analyzed by immunoblotting for the presence of phosphorylated-Erk (phospho-Ser133-Erk,
pErk), Erk, phosphorylated-CREB (phospho-Thr202/Tyr204-CREB, pCREB), and CREB. The graphs represent the quantitative assessments of the ratio of activated Erk/CREB over total Erk/CREB
(pErk/Erk ratio: ANOVA F(2,6) 7.410; *p 0.05, and pCREB/CREB ratio: ANOVA F(2,5) 126.737; ***p 0.001). D, bdnf exon IIA, IIB, IIC, and IV transcripts levels as determined by quantitative
PCR analysis (n 6 hippocampi per group; exon IIA: ANOVA F(2,15) 0.137, p 0.8730; exon IIB: ANOVA F(2,15) 0.47, p 0.6336; exon IIC: ANOVA F(2,15) 0.257, p 0.7769; exon IV: ANOVA
F(2,17) 4.365, p 0.0295). All graphs, Values plotted are meanSEM. Significant ANOVAs were followed up with Fisher’s PLSD test; *p 0.05, **p 0.01 and ***p 0.001.
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Figure5. S1181A/S1201A-HTTpromotesmicrotubule-basedBDNF transport and release.A, Anterograde and retrograde transports of BDNF-mCherry-containing vesicles are analyzed in primary
cultures of rat hippocampal neurons coelectroporated as indicated with constructs expressing the first N-terminal 1301 aa of wild-type HTT with HTT-1301 (HTT), HTT-1301-S1181A/S1201A
(HTT-AA), or HTT-1301-S1181D/S1201D (HTT-DD), siRNA targeting HTT (siHTT) and BDNF-mCherry (vesicles number: n 42 for each condition; anterograde velocity: ANOVA F(2,132) 9.376;
***p 0.001; retrograde velocity: ANOVA F(2,132) 7.613; ***p 0.001 and pausing time: ANOVA F(2,132) 6.443; **p 0.01). Data were obtained from three independent experiments.
B, Transport-dependent BDNF release is evaluated after two KCl-induced depolarizations in hippocampal neurons coelectroporated as indicated with siRNA targeting HTT (siHTT) and HTT-1301 (HTT), or
HTT-1301-S1181A/S1201A (HTT-AA) or HTT-1301-S1181D/S1201D (HTT-DD) and BDNF. Release is expressed as a K2/L (L, lysate) ratio (ANOVA F(2,6) 11,390; **p 0.01). Data were obtained
from three independent experiments. C, Anterograde and retrograde transports of BDNF-mCherry-containing vesicles are analyzed in primary cultures of cortical neurons (Figure legend continues.)
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2008). We found no difference in the phosphorylation status
of S421 in hippocampal protein extracts from wild-type,
HdhS1181A/S1201A, and HdhS1181D/S1201D animals (data not
shown). This is in agreement with the fact that the regulatory
effect of S1181/S1201 applies to both an-
terograde and retrograde transport. This
suggests that phosphorylating S421 and
S1181/S1201 have differential conse-
quences for the function of HTT as a dy-
nein/dynactin scaffold.
Typical symptoms of HD include per-
sonality changes, cognitive deterioration,
involuntary choreiform movements, and
hypokinesia. Psychiatric disturbances and
personality changes are among the first
symptoms to appear in patients. Depres-
sion is prevalent, and is often manifest
before the diagnosis of the disease (Kirk-
wood et al., 2001; Duff et al., 2007). Duff
et al. (2007) showed that nondiagnosed
HD carriers have greater levels of depres-
sion than expansion-negative at-risk indi-
viduals. In parallel, several studies have
investigated how adult neurogenesis is af-
fected in the brains of HD mouse models
(for review, see Gil-Mohapel et al., 2011).
The functional consequences of these al-
terations have not been directly ad-
dressed, but it is tempting to speculate
that a compromised neurogenic process
might contribute, at least in part, to the
occurrence of depression in these models.
Adult neurogenesis in two locations has
been studied: the dentate gyrus of the hip-
pocampus and the subventricular zone
(SVZ) adjacent to the lateral ventricles.
Defects in the proliferation of progeni-
tors, and differentiation and maturation
of newborn neurons in adult HD mouse
hippocampus have been reported. No sig-
nificant alteration in adult neurogenesis
in the SVZ has been observed in the same
mouse models. In contrast, in postmor-
tem samples fromHDpatients, adult neu-
rogenesis in the SVZ is impaired, and
there is greater than normal cell prolifer-
ation (Curtis et al., 2003, 2012). Here, we
suggest that the depressive behavior ob-
served in patients is not just an epiphe-
nomenon to a fatal disorder, but the result
of the modification in the biological func-
tion of HTT in the control of mood disorders.
Exogenous expression of the first 1301 aa of HTT with S1181/
S1201 substitutions leads to toxicity in primary culture of striatal
neurons by a p53-dependent pathway (Anne et al., 2007). Nota-
bly, treatment of striatal neurons in culture with camptothecin, a
specific inhibitor of topoisomerase, increases cell death when
huntingtin could not be phosphorylated. In contrast, we do not
observe a general increase in cell death in the brains of
HdhS1181A/S1201Amice. Themost prominent effect of unphospho-
rylatable HTT in newly generated neurons of the hippocampus is
the effect on their survival and maturation. The discrepancies
between these studies might be related to the different experi-
mental conditions. In particular, absence of phosphorylation
might induce different pathways with distinct outputs according
to the cellular context. Future studies are required to establish
whether under specific challenges such as DNA damage, the
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(Figure legend continued.) fromwild-type, HdhS1181A/S1201A and HdhS1181D/S1201Dmice elec-
troporated with BDNF-mCherry (vesicles number: wild-type n 46; HdhS1181A/S1201A n 59;
HdhS1181D/S1201D n 32; anterograde velocity: ANOVA F(2,134) 8.906; ***p 0.001; retro-
grade velocity: ANOVA F(2,134) 4.735; *p 0.05 and pausing time: ANOVA F(2,134) 4.872;
**p  0.01). Data were obtained from three independent experiments. D, Representative
kymographs of BDNF-mCherry-containing vesicles dynamics. E, Transport-dependent BDNF
release is evaluated after two KCl-induced depolarizations of cultured cortical neurons from
wild-type, HdhS1181A/S1201A, and HdhS1181D/S1201D mice electroporated with BDNF. Release is
expressed as a K2/L ratio (ANOVA F(2,6) 10.311; *p 0.05). Data were obtained from three
independent experiments. All graphs, Values plotted are meanSEM. Significant ANOVAs
were followed up with Fisher’s PLSD test; *p 0.05, **p 0.01, and ***p 0.001.
Figure 6. The S1181/S1201 phosphorylation status of HTT regulates motors and BDNF vesicles attachment tomicrotubules. A,
MT fractionation of HeLa cells expressing HTT-1301 (HTT), HTT-1301-S1181A/S1201A (HTT-AA), or HTT-1301-S1181D/S1201D
(HTT-DD). Samples are analyzed by immunoblotting for the presence of HTT, p150Glued, and dynein (DIC, dynein intermediate
chain). The graphs represent the ratios of HTT (ANOVA F(2,12) 4.335; *p 0.05), p150
Glued (ANOVA F(2,12) 4.372; *p 0.05),
and DIC to tubulin (ANOVA F(2,12) 4.028; *p 0.05). Values refer to band densities. S, supernatant; P, pellet corresponding to
the MT-enriched fraction. Data are from five independent experiments. B, Cells express HTT-1301 (HTT), HTT-1301-S1181A/
S1201A (HTT-AA), or HTT-1301-S1181D/S1201D (HTT-DD) and BDNF-mCherry. Cells are immunostained for the presence of BDNF
(red) and -tubulin (green). Scale bar, 5 m and for the magnification: 1 m. The graph represents the quantifications of
BDNF-mCherry vesicles localized onMTs for each conditions (ANOVA F(2,106)3234; *p0.05). Data are from three independent
experiments. All graphs, Values plotted aremeanSEM. Significant ANOVAswere followedupwith Fisher’s PLSD test; *p0.05,
**p 0.01, and ***p 0.001.
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HdhS1181A/S1201Amouse line is more prone to increased cell death
or to develop HD related symptoms.
S1181/1201 are Cdk5 phosphorylation sites (Anne et al.,
2007). Consistent with our results, a recent report suggests that
Cdk5/p35 participates in depression-like behavior in rat through
a neurogenesis-dependent mechanism. Cdk5 activity is induced
in the hippocampus upon the chronic mild stress (CMS) proce-
dure that leads to a depressive phenotype (Zhu et al., 2012). The
authors show that hippocampal Cdk5 activity is required to in-
duce the CMS depressive-related behavior. Moreover, antide-
pressants decrease Cdk5 activity.
Cdk5 has been implicated in a wide range of cellular mech-
anisms including those contributing to embryonic and adult
neurogenesis (Jessberger et al., 2009; Su and Tsai, 2011). In the
adult brain, Cdk5 regulates spine formation. Overactivation of
Cdk5 leads to a transient increase in dendritic spine density in
the adult hippocampus, followed by a reduction in spine for-
mation (Fischer et al., 2005). Another study showed that inhi-
bition of Cdk5 activity in newly generated neurons of the adult
hippocampus interferes with the formation of mature spines
(Jessberger et al., 2008). Interestingly, the genetic ablation of
Cdk5 from hippocampal neurons specifically impacts on the
survival and maturation of neurons, but not on their prolifer-
ation (Lagace et al., 2008). What are the molecular mecha-
nisms underlying the effects of Cdk5 in hippocampal
neurogenesis and behavior in rodent models? Here we pro-
pose that HTT-mediated BDNF axonal transport by Cdk5may
be involved. Indeed, our findings are in agreement with the
reported role of Cdk5 in the regulation of anterograde and
retrograde axonal transport (Morfini et al., 2004; Shea et al.,
2004; Pandey and Smith, 2011). However, the literature does
not always fit with the absence of HTT phosphorylation, cor-
responding to low Cdk5 activity, leading to increased trans-
port and neurogenesis. In our experimental systems (this work
and Anne et al., 2007), constitutively S1181/S1201 phosphor-
ylated HTT behaves like the wild-type HTT. Possibly, HTT is
constitutively phosphorylated by Cdk5, and it is the dephos-
phorylation event which is the critical switch leading to the
dynamic regulation of induced molecular mechanisms.
BDNF is a neurotrophin involved in mood disorders.
BDNF is less abundant in postmortem tissue taken from pa-
tients with major depression disorder and in the serum of
patients with major depression disorder than controls (Autry
andMonteggia, 2012). Most effective treatments of depression
stimulate BDNF production; they include electroconvulsive
therapy, classical antidepressant drugs, and repetitive trans-
cranial magnetic stimulation. Patients treated with antide-
pressants long-term show increased levels of BDNF in their
serum and hippocampus (Duman and Monteggia, 2006).
BDNF is essential for adult neurogenesis in the hippocampus
where it specifically increases maturation and survival of the
newly generated neurons (Scharfman et al., 2005; Krishnan
and Nestler, 2008). It is less clear whether BDNF has a role in
cell proliferation. This may be because progenitors are more
likely to express TrkB as their morphology become more ma-
ture (Donovan et al., 2008). Note that in our HdhS1181A/S1201A
mouse line, neuronal maturation and survival are greater than
in controls but no effect on proliferation was detected. This
underlines the specific effect of unphosphorylatable HTT on
BDNF.
ProBDNF is processed to mature BDNF by several mecha-
nisms (Lu et al., 2005). The question of whether proBDNF is
transient as it is rapidly converted to mature BDNF, or
whether it functions as an extracellular ligand is a matter of
discussion (Matsumoto et al., 2008; Yang et al., 2009). Both
pathways could coexist according to several factors. The site of
BDNF production is essential as the enzymes responsible for
BDNF maturation have precise subcellular localization. In ad-
dition, the conversion could be developmentally regulated
with proBDNF actions that may be more robust during post-
natal development compared with adulthood. Furthermore,
the nature of the BDNF transcript is crucial for its targeting. In
our experimental paradigm, we found a specific enrichment in
mature BDNF versus proBDNF. We also showed that specific
bdnf transcripts are elevated in the presence of S1181/S1201
unphosphorylated huntingtin. One could speculate that these
transcripts would be preferentially distributed to cellular
compartments where they would be processed rapidly. In ad-
dition, extracellular proBDNF might either have a short half-
life or act rapidly as a ligand that is endocytosed.
Several classes of drugs with antidepressant activity have been
developed. Nevertheless, many patients do not respond to the
molecules currently available, and for many others the effects are
incomplete (Kupfer et al., 2012). As a consequence, new classes of
antidepressant need to be developed and this will inevitably re-
quire a sound understanding of the neurobiological basis of this
complex disease. The observation that HTT is a determinant of
mouse anxiety/depression-related behavior identifies HTT as a
component of the pathways regulating mood disorders. Our
work thus suggests that it may constitute a novel target for ther-
apy for anxiety and depression not only in HD but also in mood
disorders.
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